Agency stressed that inappropriate use of these drugs may pose risks to users’ health; New Standard will start to be valid 60 days after the official publication of the resolution
The (National Health Surveillance Agency) announced on Wednesday (16) that the sale of weight loss pens such as Wegovy and Mounjaro will be regulated with the requirement of retention of revenue in pharmacies. This decision aims to curb the purchase of these drugs without prescription. The new standard will start to be 60 days after the official publication of the resolution. Currently, these products are classified as red stripe, however, many Brazilians have been able to buy them without proper guidance. With the new rule, retention of revenue will be made by the duplicate, and pharmacists will not be able to accept revenues that are out of the expiration date of 90 days, in cases of extended treatment.
The agency stressed that inappropriate use of these medicines may pose risks to users’ health. Data indicate that 32% of adverse event notifications related to these products are associated with unauthorized use. The World Health Organization (WHO) points out that the global rate would be 10%.
Anvisa will monitor handling pharmacies, which are still allowed to operate in the market. In addition, drugstores will need to include in the National Controlled Product Management System (SNGPC) the movement of purchase and sale of these medications, whether industrialized or manipulated. The proposed retention of revenue received support from Ansoo and various medical societies, which expressed concern with the aesthetic use of LPG-1 agonists. These entities emphasized the importance of medical follow -up to avoid health risks and ensure that treatments reach those who really need it.
*Report produced with the aid of AI
Posted by Nátaly Tenório
